{
    "id": "dbf084abd0",
    "level": "sentence",
    "abstract": [],
    "body_text": [
        {
            "text": "Methylation microarray data has been deposited at NCBI Gene Expression Omnibus data repository (GEO; http://www.ncbi.nlm. nih.gov/geo/) with accession number GSE54719 (http://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc=GSE54719); on superseries record GSE54721 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc=GSE54721)."
        },
        {
            "text": "To define the DNA methylation landscape of neuroblastoma and its potential clinicopathological impact. ",
            "section": "Experimental design"
        },
        {
            "text": "Microarray DNA methylation data (Infinium Human Methylation 450k BeadChip) were analyzed and associated with functional/regulatory genome annotation data, transcriptional profiles and clinico-biological parameters.",
            "section": "Experimental design"
        },
        {
            "text": "Thirty-five primary neuroblastoma tumors (including 6 stage 1, 9 stage 3, 6 stage 4s and 14 stage 4) obtained at the time of diagnosis   Table 1. ",
            "section": "Patients and samples",
            "ref_spans": [
                {
                    "start": 137,
                    "end": 144,
                    "type": "table",
                    "ref_id": "tab_1",
                    "text": "Table 1"
                }
            ]
        },
        {
            "text": "Tumors were evaluated by a pathologist, only samples with more than 70% viable tumor cell content were included in the study. ",
            "section": "Patients and samples"
        },
        {
            "text": "This study was approved by the Institutional Review Boards. ",
            "section": "Patients and samples"
        },
        {
            "text": "Informed consent was obtained before collection of samples. ",
            "section": "Patients and samples"
        },
        {
            "text": "Genomic DNA was isolated from samples using Wizard DNA Purification Kit (Promega Biotech Ib\u00e9rica, Spain), following manufactures' protocols.",
            "section": "Patients and samples"
        },
        {
            "text": "Genomic DNA bisulfite conversion and hybridization to Infinium Human Methylation 450k BeadChip (Illumina Inc., San Diego, CA) was performed at the Human Genotyping Unit of the Spanish National Cancer Center (CEGEN-CNIO, Madrid, Spain), as described previously [9].",
            "section": "DNA methylation microarrays",
            "ref_spans": [
                {
                    "start": 260,
                    "end": 263,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "[9]"
                }
            ]
        },
        {
            "text": "Microarray data was analyzed by minfi [10] and shinyMethyl [11] packages available through Bioconductor [12]. ",
            "section": "Quality control",
            "ref_spans": [
                {
                    "start": 38,
                    "end": 42,
                    "type": "bibr",
                    "text": "[10]"
                },
                {
                    "start": 59,
                    "end": 63,
                    "type": "bibr",
                    "text": "[11]"
                },
                {
                    "start": 104,
                    "end": 108,
                    "type": "bibr",
                    "text": "[12]"
                }
            ],
            "entity_spans": [
                {
                    "start": 32,
                    "end": 37,
                    "type": "software",
                    "rawForm": "minfi",
                    "resp": "#annotator5",
                    "used": true,
                    "id": "dbf084abd0-software-simple-0",
                    "cert": "0.8"
                },
                {
                    "start": 47,
                    "end": 58,
                    "type": "software",
                    "rawForm": "shinyMethyl",
                    "resp": "#annotator5",
                    "used": true,
                    "id": "dbf084abd0-software-simple-1",
                    "cert": "0.8"
                },
                {
                    "start": 91,
                    "end": 103,
                    "type": "software",
                    "rawForm": "Bioconductor",
                    "resp": "#annotator5",
                    "used": true,
                    "id": "dbf084abd0-software-simple-2",
                    "cert": "0.9"
                }
            ]
        },
        {
            "text": "Single cytosine methylation values (\u03b2-values) in each sample were calculated as the ratio of the methylated signal intensity to the sum of methylated and unmethylated signals. ",
            "section": "Quality control"
        },
        {
            "text": "Methylation values ranged from 0, fully unmethylated, to 1, fully methylated cytosine. ",
            "section": "Quality control"
        },
        {
            "text": "Raw methylation \u03b2-value plots were performed for all samples to identify possible deviant samples (Fig. 1 & B).",
            "section": "Quality control",
            "ref_spans": [
                {
                    "start": 98,
                    "end": 110,
                    "type": "figure",
                    "text": "(Fig. 1 & B)"
                }
            ]
        },
        {
            "text": "Sample quality was assessed using the log median intensity in both the methylated and unmethylated channels (Fig. 1C).",
            "section": "Quality control",
            "ref_spans": [
                {
                    "start": 108,
                    "end": 117,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "(Fig. 1C)"
                }
            ]
        },
        {
            "text": "Principal component analysis (PCA) was performed on the 20,000 most variable autosomal probes in order to analyze associations between sample type (adrenal gland, ganglioneuroma, fetal brain or neuroblastoma) and methylation levels (Fig. 2).",
            "section": "Quality control",
            "ref_spans": [
                {
                    "start": 232,
                    "end": 240,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "(Fig. 2)"
                }
            ]
        },
        {
            "text": "Microarray methylation data was normalized by missMethyl package [13] using the SWAN (subset-quantile within array normalization), a within-array normalization method for Illumina Human Methylation 450k BeadChips (Fig. 3).",
            "section": "Data normalization",
            "ref_spans": [
                {
                    "start": 65,
                    "end": 69,
                    "type": "bibr",
                    "text": "[13]"
                },
                {
                    "start": 213,
                    "end": 221,
                    "type": "figure",
                    "text": "(Fig. 3)"
                }
            ],
            "entity_spans": [
                {
                    "start": 46,
                    "end": 56,
                    "type": "software",
                    "rawForm": "missMethyl",
                    "resp": "#annotator5",
                    "used": true,
                    "id": "dbf084abd0-software-simple-3",
                    "cert": "0.8"
                }
            ]
        },
        {
            "text": "An optimized pipeline with several filters developed at the IDIBAPS was used to exclude technical biases, [14,15]. ",
            "section": "Filtering of microarray data",
            "ref_spans": [
                {
                    "start": 106,
                    "end": 110,
                    "type": "bibr",
                    "ref_id": "b13",
                    "text": "[14,"
                },
                {
                    "start": 110,
                    "end": 113,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "15]"
                }
            ]
        },
        {
            "text": "Cytosines with poor detection P-values (P N 0.01) and those with sex-specific DNA methylation (n = 6926) were removed from the initial dataset of 485,512 sites (excluding probes detecting SNPs). ",
            "section": "Filtering of microarray data"
        },
        {
            "text": "The remaining sites (n = 478,169) were used for downstream analyses (Fig. 4).",
            "section": "Filtering of microarray data",
            "ref_spans": [
                {
                    "start": 68,
                    "end": 75,
                    "type": "figure",
                    "text": "(Fig. 4"
                }
            ]
        },
        {
            "text": "DNA methylation data were validated by bisulfite pyrosequencing as previously described [15,16]  (Fig. 5).",
            "section": "Bisulfite pyrosequencing",
            "ref_spans": [
                {
                    "start": 88,
                    "end": 92,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "[15,"
                },
                {
                    "start": 92,
                    "end": 95,
                    "type": "bibr",
                    "ref_id": "b15",
                    "text": "16]"
                },
                {
                    "start": 97,
                    "end": 104,
                    "type": "figure",
                    "ref_id": "fig_5",
                    "text": "(Fig. 5"
                }
            ]
        },
        {
            "text": "The analysis of the DNA methylome of neuroblastoma patients revealed that: ",
            "section": "Data summary"
        },
        {
            "text": "i) most DNA methylation changes take place outside promoters, ",
            "section": "Data summary"
        },
        {
            "text": "ii) not only CpGs but also non-CpG sites are targeted, ",
            "section": "Data summary"
        },
        {
            "text": "iii) methylation changes at these sites are associated with clinicopathological features of neuroblastoma, and ",
            "section": "Data summary"
        },
        {
            "text": "iv) the identified epigenetic patterns provide new insights into the pathogenesis and clinical behavior of this pediatric tumor. ",
            "section": "Data summary"
        },
        {
            "text": "The analysis of this data has been reported in our recently published study [15].   ",
            "section": "Data summary",
            "ref_spans": [
                {
                    "start": 76,
                    "end": 80,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "[15]"
                }
            ]
        },
        {
            "text": "and bisulfite pyrosequencing (X-axis) (n = 11). ",
            "section": "Data summary"
        },
        {
            "text": "A highly significant correlation (P b 0.001, R 2 = 0.978 and R 2 = 0.968, respectably) between microarray and pyrosequencing data was observed. ",
            "section": "Data summary"
        },
        {
            "text": "Example of pyrograms with methylated (B) and unmethylated (C) cytosines.",
            "section": "Data summary"
        },
        {
            "text": "The authors acknowledge G. Garcia-Castellv\u00ed for the fund raising and the \"Biobanc de l'Hospital Infantil Sant Joan de D\u00e9u per a la Investigaci\u00f3\" integrated in the National Network Biobanks of ISCIII for tissue samples. ",
            "section": "Acknowledgments"
        },
        {
            "text": "The authors also thank J. R\u00edos for statistical advice and S. S\u00e1nchez Molina for precious technical support.",
            "section": "Acknowledgments"
        }
    ]
}